Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$766M |
| 2 |
Adobe
ADBE
|
$529M |
| 3 |
Merck
MRK
|
$463M |
| 4 |
Tesla
TSLA
|
$359M |
| 5 |
AGN
Allergan plc
AGN
|
$339M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$714M |
| 2 |
Gilead Sciences
GILD
|
$600M |
| 3 |
Perrigo
PRGO
|
$585M |
| 4 |
EMC
EMC CORPORATION
EMC
|
$448M |
| 5 |
Morgan Stanley
MS
|
$423M |
Sector Composition
| 1 | Healthcare | 17.95% |
| 2 | Consumer Discretionary | 15% |
| 3 | Communication Services | 10.58% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
TransDigm Group
TDG
$71.6B
| $111M | 0.11% |
687,956
-573,786
| -45% | -$92.4M |
|
177
Oneok
OKE
$45.7B
| $109M | 0.11% |
2,001,998
+133,724
| +7% | +$7.28M |
|
178
Range Resources
RRC
$8.27B
| $108M | 0.11% |
1,285,414
-28,646
| -2% | -$2.42M |
|
179
East-West Bancorp
EWBC
$14.8B
| $108M | 0.11% |
3,091,580
-39,096
| -1% | -$1.37M |
|
|
DATA
180
DELISTED
Tableau Software, Inc.
DATA
| $108M | 0.11% |
1,564,361
+1,424,697
| +1,020% | +$98.2M |
|
181
NRG Energy
NRG
$28.6B
| $107M | 0.11% |
3,742,943
-76,286
| -2% | -$2.19M |
|
182
Albemarle
ALB
$9.6B
| $107M | 0.11% |
1,688,937
-28,916
| -2% | -$1.83M |
|
183
Energy Transfer Partners
ET
$59.7B
| $107M | 0.11% |
5,236,520
+794,560
| +18% | +$16.2M |
|
184
Cogent Communications
CCOI
$1.81B
| $107M | 0.1% |
2,639,615
-164,769
| -6% | -$6.66M |
|
185
Zoetis
ZTS
$67.9B
| $106M | 0.1% |
3,242,563
+2,111,935
| +187% | +$69M |
|
|
SPN
186
DELISTED
Superior Energy Services, Inc.
SPN
| $105M | 0.1% |
3,964,292
+98,909
| +3% | +$2.63M |
|
187
NextEra Energy, Inc.
NEE
$146B
| $105M | 0.1% |
4,905,608
-93,468
| -2% | -$2M |
|
188
Standard BioTools
LAB
$497M
| $103M | 0.1% |
2,690,748
-679,712
| -20% | -$26M |
|
189
Sanofi
SNY
$113B
| $102M | 0.1% |
1,905,142
+355,785
| +23% | +$19.1M |
|
|
HES
190
DELISTED
Hess
HES
| $102M | 0.1% |
1,227,152
+728,894
| +146% | +$60.5M |
|
191
Lumen
LUMN
$4.87B
| $102M | 0.1% |
+3,188,024
| New | +$102M |
|
192
Sempra
SRE
$52.9B
| $101M | 0.1% |
2,258,556
+162
| +0% | +$7.27K |
|
|
MNDT
193
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $101M | 0.1% |
+2,322,214
| New | +$101M |
|
|
CAVM
194
DELISTED
Cavium, Inc.
CAVM
| $100M | 0.1% |
2,908,011
+429,792
| +17% | +$14.8M |
|
195
Capital One
COF
$142B
| $99.8M | 0.1% |
1,303,086
-15,281
| -1% | -$1.17M |
|
196
Bread Financial
BFH
$3.09B
| $97.5M | 0.1% |
464,569
-346,371
| -43% | -$72.7M |
|
197
Celldex Therapeutics
CLDX
$1.52B
| $96.4M | 0.09% |
265,454
-19,404
| -7% | -$7.05M |
|
|
XEC
198
DELISTED
CIMAREX ENERGY CO
XEC
| $96.1M | 0.09% |
915,914
-104,924
| -10% | -$11M |
|
199
GameStop
GME
$10.1B
| $95.4M | 0.09% |
7,747,444
+161,620
| +2% | +$1.99M |
|
200
OGE Energy
OGE
$8.89B
| $94M | 0.09% |
2,773,570
| – | – |
|